The first product from Syngenta’s acquisition of Pasteuria Bioscience, Clariva, has been launched and will be available in the U.S. next year.
Syngenta announced today the launch of CLARIVA™, a proprietary seed treatment nematicide based on the Pasteuria technology acquired in 2012.
CLARIVA consists of naturally occurring soil bacteria with a unique, direct mode of action on nematodes: microscopic worm-shaped soil organisms, which cause significant damage to all major agricultural crops.
CLARIVA will be available in the USA for the 2014 growing season. It will be combined with other leading Syngenta seed care compounds as a complete solution for soybeans. Further registrations across major crops worldwide are planned.